Bristol-Myers Squibb CompanyBMY
Healthcare · Drug Manufacturers - General
Scored 2026-07-07 · updates weekly
What’s driving the score
100 is the best score. The small percentage shows how much each factor counts. Hover a factor name for what it means. “n/a” means that factor doesn’t apply to this type of company (banks and REITs work differently), so the other factors count more.
The bottom line
As of 2026-07-07, Bristol-Myers Squibb (BMY) scores 57.8 out of 100 on the Dividend Safety Checker scale, which rates its dividend Borderline. In our testing, roughly 1 in 10 stocks with this rating cut their dividend within a year, so it belongs on a watch list.
The strongest parts of the picture are years since last cut, revenue growth, yield vs its own history. The main things holding the score back are dividend growth (1y) (scoring 0 out of 100) and profit steadiness (0 out of 100). Dividend growth over the past year. Companies usually freeze the dividend before they cut it.
Bristol-Myers Squibb currently yields 3.2%, has gone at least 20 years without cutting its dividend, pays out 43% of its free cash flow as dividends. The score updates weekly as new filings and prices come in.
Common questions
Is Bristol-Myers Squibb's dividend safe?
As of 2026-07-07, Bristol-Myers Squibb (BMY) scores 57.8 out of 100 on the Dividend Safety Checker scale, which rates its dividend Borderline. In our testing, roughly 1 in 10 stocks with this rating cut their dividend within a year, so it belongs on a watch list.
How likely is BMY to cut its dividend in the next 12 months?
Bristol-Myers Squibb is rated Borderline (score 57.8 of 100). In our testing, roughly 1 in 10 stocks with this rating cut their dividend within a year, so it belongs on a watch list. The rating comes from a formula tested against every US dividend cut from 2008 to 2025.
When did Bristol-Myers Squibb last cut its dividend?
Bristol-Myers Squibb has not cut its dividend in at least 20 years, as far back as our payment records reach.
What is Bristol-Myers Squibb's dividend yield?
As of 2026-07-07, Bristol-Myers Squibb yields 3.2% based on its trailing 12 months of regular dividend payments.
How is this dividend safety score calculated?
The score combines 12 measurable factors: payout ratios, debt, profit steadiness, yield versus the stock's own history, and the company's cut record. Each factor is graded against 18 years of real dividend-cut history. The full method is public at dividendsafetychecker.com/methodology.
Answers are generated from the latest model run and refresh with each rescore. Not investment advice. See how the score works.
Get a free alert if Bristol-Myers Squibb's rating drops
We recheck BMY and every stock we track each week. When any of them gets downgraded, subscribers hear about it first. No spam, unsubscribe anytime.
Share it
Download the score card as an image to post or send.
Want to know how this is calculated? The whole method is public, and so is its track record. Or browse more Healthcare dividend stocks.